Clinical, paraclinical, and sociodemographic prostate cancer patient’s at the University Hospital Hernando Perdomo Moncaleano in Neiva

Características clínicas, paraclínicas y sociodemográficas de pacientes con cáncer de próstata en el hospital Universitario Hernando Moncaleano Perdomo de Neiva

##plugins.themes.bootstrap3.article.main##

Gustavo Borrero
Claudia González
Gilberto Astaiza
Abstract

A descriptive-observational, analytical and qualitative study with a retrospective crosssectional component was carried out aiming at having a deeper view of prostate cancer patients. It took place at the Hernando Moncaleano Perdomo Hospital in Neiva from January 1st , 2000 to August 31st , 2002. 

The sample was made up of 45 patients diagnosed with prostate cancer after pathological tests. The study variable were: age, origin, social security, caracteristics, level of PSA (Prostatic Specific Antigen), diagnostic methods, metastasis presence, histological characteristics and treatment.

Epi Info 2002 Program was used to code and process data. Cause-type relations were not searched among variabales, but a covariation relation was established among them.

Main results are: 37% of patients come from Neiva, 60% of patients live in the urban area, they are aged between 56 and 89, higher frequency was found among patients over 70 years old (67%), only two patients (4,4%) were found to have prostate cancer familiar background, at the time of the diagnosis test PSA levels were found to be increased (100%), and rectal tactus shows a big (88.9%) stone consistency prostate gland (62%), the histological type in all patients is adenocarcinoma. 

There is evidence of bone metastasis (38,5%), and lung metastasis (10%), the selected treatment was prostatectomy (47%) and bilateral orchidectomy (51%).

Keywords

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

Author Biographies / See

Gustavo Borrero, Universidad Surcolombiana

Médico

Claudia González, Universidad Surcolombiana

Medico

Gilberto Astaiza, Universidad Surcolombiana

Profesor Asociado, Departamento de Medicina Social y Preventiva. Facultad de Salud
References

Weinger WK., Barry MJ. Quality-of-life impact of lower urinary tract symptom severity results from the health professionals follow-up study. Urology. 2002. 59, 245.

DuBeau CE. The aging lower urinary tract. Journal of Urology. 2006.175 S11-S15.

Mifsud A, Choon AT, Fang D, Yong EL. Prostate-specific antigen, testosterone, sexhormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men. Molecular Human Reproduction. 2001;7:1007-1013.

Cybulski C, Wokołorczyk D, Jakubowska A, et al. DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urolology International. 2007. 79; 44- 49.

Nelson WG. De Marzo AM.William, Isaac WB; Prostate cancer. The New England Journal of Medicine. 2003. 349; 366-81.

Ballentine C, Pearson J, Guess HA, Ross KS. Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection. The journal of the American medical association JAMA. 2000; 284:1399-1405.

Cajigas JA, Schlesinger R, Hernández J, Rangel J, Quiroga W y Vallejo F. Cáncer de próstata en el hospital militar central. Revista de Urología. Hospital Militar Central.2000.

Cajigas JA, Quiroga W. Prostatectomía radical en hombres mayores de 70 años. Revista del Hospital Universitario La Samaritana. 2000.

Stanford J, et al. The prostate cancer outcomes study. JAMA. 2000; 283:354-360.

Hellerstedt B, Kenneth P. The current state of hormonal therapy for prostate cancer. Cancer Journal Clinicians. 2002; 52:154-179.

OJS System - Metabiblioteca |